Normal and Pathological Erectile Function The Potential Clinical Role of Endothelin-1 Antagonists
Journal:
Current Drug Targets
Volume:
1
Page:
247-260
Author(s):
M. A. Khan, R. C. Calvert, M. E. Sullivan, C. S. Thomson, F. H. Mumtaz, R. J. Morgan and D. P. Mikhailidis
Membrane Transporters and Antifungal Drug Resistance
Journal:
Current Drug Targets
Volume:
1
Page:
261-284
Author(s):
Vassil St. Georgiev
Mutagenesis in Mice Modern Times
Journal:
Current Genomics
Volume:
1
Page:
253-258
Author(s):
John C. Schimenti
COX-2 in Brain and Spinal Cord - Implications for Therapeutic Use.
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
1113-1120
Author(s):
C. Hoffmann
Toxicokinetics in Drug Development: An Overview of Toxicokinetic Application in the Development of PNU-101017, an Anxiolytic Drug Candidate
Journal:
Current Drug Metabolism
Volume:
1
Page:
243-254
Author(s):
W. Z. Zhong, M. G. Williams and D. G. Branstetter
Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1755-1776
Author(s):
A. Yermakova and M. K. O'Banion
Docosahexaenoic Acid and Membrane Lipid Domains
Journal:
Current Organic Chemistry
Volume:
4
Page:
1169-1183
Author(s):
William Stillwell
Measuring Receptor Occupancy with PET
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1593-1610
Author(s):
Aren van Waarde
PET Studies of Brain Monoamine Transporters
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1611-1623
Author(s):
Aki Laakso and Jarmo Hietala
Regional Pharmacokinetics of Orally Administered PET Tracers
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1625-1629
Author(s):
Alan J. Fischman, Ali A. Bonab and Robert H. Rubin